By Ana S. Iltis, Grace Koster, Emily Reeves & Kirstin R. W. Matthews

Abstract

Recent advances in methods to culture…

Abstract

Purpose – Despite the progression of recreational cannabis legalization, the legal system remains the largest…

Abstract

Scholars began reporting about this marketplace in the mid-2000s; however, there is no sign of it dissipating…

On October 12, 2022, Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy, testified before the Texas House of Representatives Interim Study Committee on Criminal Justice Reform. Her written testimony addresses the committee's inquiry into policies and penalties relating to drug offenses.

Vaccination policies are a cornerstone of public health, but anti-vaccine activists have been adamantly pushing for legislation that would weaken and dismantle the public health infrastructure, the authors write. In this issue brief, they examine vaccine policy challenges leading up to and during the COVID-19 pandemic, as well as the future of vaccine legislation in Texas and the United States.

The authors identify key themes that emerged from anti-vaccine testimonies during the 2021 Texas legislative session and consider the implications of these discussions as the next legislative session draws near.

Abstract

The protection of critical infrastructure (water, energy, food supply, healthcare etc.) from cyberattack has…

Information and cyber action have been important but ancillary components of the Ukraine war since its outbreak on February 24, 2022. We offer a set of observations:

There have been promising developments in recent years in the fight to reduce overdose deaths. But barriers to drug checking and other overdose prevention tools remain throughout the country, writes fellow Katharine Neill Harris.

Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.